ArticleJournal of oncology2022

Application of Arsenic Trioxide-Based Combined Sequential Chemotherapy in Recurrent Resistant and Refractory Ovarian Cancers: A Single-Center, Open Phase II Clinical Study.

Yingchao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.